Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has retained Brian Higley, a securities attorney based in Utah, to serve as securities counsel to the Company. Mr. Higley advises public companies on corporate governance, securities law compliance, regulatory matters, and capital markets activities. In this role, he will assist the Company with ongoing securities law compliance, regulatory filings, and other corporate legal matters as the Company continues executing its strategic transition into artificial intelligence-enabled healthcare technology.
Mr. Higley is listed on the OTC Markets website as one of a limited group of Premium Legal Service Providers, a designation that identifies experienced securities attorneys who assist public companies with regulatory compliance, disclosure matters, and capital markets activities. According to OTC Markets, only nine legal service providers are currently listed within this premium category on the OTC Markets website.
“Maintaining strong governance and regulatory compliance is an important priority for the Company,” said Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. “We are pleased to work with Mr. Higley as we continue strengthening the Company’s legal and compliance infrastructure as a public company.”
The engagement reflects the Company’s continued commitment to maintaining appropriate legal, governance, and regulatory compliance frameworks as it advances its strategic initiatives into AI-enabled healthcare technology. Catalyst Crew Technologies is focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms designed to improve access, efficiency, and care coordination.
By appointing a securities counsel with premium designation from OTC Markets, the Company signals to investors and regulators its dedication to high standards of corporate governance. This move is particularly significant as the Company is a development-stage enterprise that has not yet generated revenues from its newly announced business direction. Strong legal oversight can help mitigate risks associated with securities law compliance and regulatory filings, which are critical for maintaining investor confidence and access to capital markets.
The appointment also underscores the growing importance of robust governance frameworks for companies undergoing strategic transitions. As Catalyst Crew Technologies pivots to AI-driven healthcare, ensuring compliance with securities regulations will be essential for executing potential acquisitions, securing financing, and navigating regulatory approvals. For more details about the Company, visit https://catalystcrewai.com, or access its official filings through the U.S. Securities and Exchange Commission website at www.sec.gov.
